Exercise News and Research

Latest Exercise News and Research

Fiscal 2009 results announced by Helix BioPharma

Helix BioPharma Corp. today announced financial results for the year ended July 31, 2009.

30 Oct 2009

Healthy eating tips for diabetics

A new case of diabetes strikes every 20 seconds. With nearly 24 million Americans of all ages affected by the disease and an additional 57 million at risk for diabetes, diabetes has reached epidemic proportions.(1) If current trends continue, one out of three children will live with diabetes sometime in their future.

30 Oct 2009

Studies on fruit-fly may lead to new treatments for sleep-disorders

New research on the fruit-fly brain points to a possible mechanism by which temperature influences the body clock, according to scientists from Queen Mary, University of London.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

UNFPA maternal health conferences wrap up

Two United Nations Population Fund (UNFPA) conferences this week in Addis Ababa, Ethiopia, gathered "international policymakers, government ministers, and lawmakers" to address the half a million maternal deaths annually, Radio Free Europe/Radio Liberty reports. Although the U.N. "hopes to reduce maternal mortality by three quarters between 1990 and 2015," this Millennium Development Goal target "has seen the least progress in recent years," the news organization writes.

29 Oct 2009

Inhibitex completes $23 million private placement of common stock and warrants

Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.

29 Oct 2009

Interleukin Genetics and Amway Global sign partnership agreement

Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.

29 Oct 2009

Neogenomics declares third quarter 2009 financial results; significantly improved liquidity position

NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.

29 Oct 2009

EB Sport announces the availability two branded fitness kits for men and women

EB Sport Group, a market leader in the creation of personal exercise and fitness products, has announced the availability of the Men’s Health “Ultimate Total-Body Workout” and Women’s Health “Lean Body Workout” – two branded fitness kits designed to get people back in shape quickly.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Curis

Curis, Inc., a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today reported its financial results for the third quarter ended September 30, 2009.

29 Oct 2009

Publix Supermarkets to sell HeartSavior and LipidShield Plus

New Health Corp. is proud to announce that HeartSavior(TM) and LipidShield® Plus are now available at Publix Supermarkets.

29 Oct 2009

Study shows 62.2 percent of women turn to alternative therapies before medical treatments for infertility

In a recent study from the Ohio State University Medical Center, 62.2 percent of those surveyed turned to alternative therapies before turning to more invasive medical treatments for infertility and getting pregnant.

29 Oct 2009

Proper diet and exercise reduce risk of type 2 diabetes

Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.

29 Oct 2009

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

29 Oct 2009

Gene variant may be the cause for bad driving: UC Irvine neuroscientists

Bad drivers may in part have their genes to blame, suggests a new study by UC Irvine neuroscientists.

29 Oct 2009

StemCells to raise $12.5 million

StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.

28 Oct 2009

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.

28 Oct 2009

PureWellness announces enhancements to the PureWellness platform

PureWellness, Inc., a leading provider of online wellness solutions, announced the release of fourteen product additions and enhancements to the PureWellness platform.

28 Oct 2009

Third-quarter fiscal 2009 results announced by Neovasc

Neovasc Inc., today announced financial results for the three and nine months ended September 30, 2009.

28 Oct 2009

Annual general meeting of shareholders to be held by China Medical Technologies

China Medical Technologies, Inc. (the "Company"), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Company's office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the People's Republic of China on November 16, 2009 at 9:00 a.m., local time.

28 Oct 2009